Journal of Intensive and Critical Care Open Access

  • ISSN: 2471-8505
  • Journal h-index: 12
  • Journal CiteScore: 2.54
  • Journal Impact Factor: 1.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Commentary - (2022) Volume 8, Issue 7

Biological Research in the Evolution of Cancer Surgery: A Personal Perspective
Sudha Sundar*
 
Department of Cancer and Genomic Sciences, University of Birmingham, UK
 
*Correspondence: Sudha Sundar, Department of Cancer and Genomic Sciences, University of Birmingham, UK, Email:

Received: 28-Jun-2022, Manuscript No. IPJICC-22-14070; Editor assigned: 30-Jun-2022, Pre QC No. IPJICC-22-14070 (PQ); Reviewed: 14-Jul-2022, QC No. IPJICC-22-14070; Revised: 19-Jul-2022, Manuscript No. IPJICC-22-14070 (R); Published: 26-Jul-2022, DOI: 10.35248/2471-8505.8.7.92

Description

Cancer surgery is an operation or procedure that removes a tumor and sometimes nearby tissue. This is the oldest form of cancer treatment and is still effective in treating many types of cancer today. Doctors who specialize in cancer surgery are called “oncologists.” Postoperative patient care in the ICU presents many challenges. Postoperative patients with active malignancies may be more difficult to treat in the intensive care unit. Nutrition, infections, and the need for postoperative mechanical ventilation support for cancer patients present challenges that may extend patient length of stay in the ICU. Critical care providers need to be aware of these challenges when caring for this patient population. Given the increasing efficacy of cancer treatment, improved prognosis, and increased life expectancy, it is expected that the number of cancer patients requiring ICU admission will continue to increase in the coming years; with intensive an area of continuing education essential to education is created. Observational studies have shown improvements in quality of life as well as mortality in cancer patients admitted to the intensive care unit. However, this is still significantly worse than the general population both at 3 and 12 months after hospital discharge, especially in haematological patients. Surgery can be done in a doctor’s office, clinic, surgery center, or hospital. Where you go depends on the type of surgery and how long it takes to heal. Surgery may require medications called anesthesia to block the perception of pain. There are different types of anesthesia, depending on the type and extent of surgery. If you have to stay in the hospital overnight or for several days after surgery, it is called inpatient surgery or you don’t need to be hospitalized at all. If you can leave the hospital on the same day, it is called outpatient surgery or ambulatory surgery. Traditionally, the main goal of cancer surgery is to cure cancer by removing everything from the body. Surgeons usually do this by cutting into the body and removing the cancer along with surrounding healthy tissue to ensure that all the cancer is removed. The surgeon may also remove some lymph nodes in the area to see if the cancer has spread. This helps the doctor assess the likelihood of recovery and the need for further treatment. For breast cancer surgery, the doctor may remove the entire breast or remove the part of the breast containing the cancer and the surrounding tissue. The cancer can be removed by removing only part of it. For lung cancer surgery, doctors may remove part or the entire lung to ensure that all cancer is removed. In either case, the surgeon may remove some lymph nodes in the area during surgery to see if the cancer has spread. Admission to the intensive care unit does not necessarily mean that all necessary measures will be taken as long as possible. We have to consider many possibilities. Patients desiring unlimited treatment for at least 5 days may be enrolled and reassessed accordingly. Intervention with hemodynamic or renal support can limit IMV. It can also be checked in to optimize comfort measurements for patients with poor prognosis or to reduce dyspnea using high-flow nasal cannulas or his IMV.

Acknowledgement

None.

Conflicts of Interest

The authors declare no conflict of interest.

Citation: Sundar S (2022) Biological Research in the Evolution of Cancer Surgery: A Personal Perspective. J Intensive Crit Care. 8:92.

Copyright: © 2022 Sundar S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.